CD4 and neoplasm: Indeed, preclinical studies have demonstrated that in the absence of MHC-II on tumor cells, adoptively transferred Trp1 CD4+ T cells still can exert antitumor immunity dependent on IFN-γ and correlate with increased cytotoxic activity of macrophages (47).